New EC Leadership Backpedals: EU Device Oversight Will Stay In Health Division-thegraysheet: Oversight of medical device and drug policy in the European Union will remain with the European Commission’s health directorate (DG Sanco), and not be switched to the internal markets/industry directorate (DG ENTR) as previously planned. The news was announced just before the European Parliament voted Oct. 22 in favor of the new European Commission, led by President Jean-Claude Juncker, which will officially begin work on Nov. 1. There were 423 votes for the new commission and its new group of commissioners, 209 votes against and 67 abstentions.
